Eli Lilly and Company(LLY)
đ Upcoming Dividend Payout
$1.50per Share
Notice is hereby given that Eli Lilly and Company will distribute a dividend of $1.5 per share on the aforementioned date of June 10, 2025.
Ex-Dividend Date:May 16, 2025
đ Dividend Highlights
Previous Payout History
85 payouts shown| Pay Date | Amount Per Share | Change vs Previous |
|---|---|---|
| March 10, 2025 | $1.50 | â˛15.38% |
| December 10, 2024 | $1.30 | - |
| September 10, 2024 | $1.30 | - |
| June 10, 2024 | $1.30 | - |
| March 8, 2024 | $1.30 | â˛15.04% |
| December 8, 2023 | $1.13 | - |
| September 8, 2023 | $1.13 | - |
| June 9, 2023 | $1.13 | - |
| March 10, 2023 | $1.13 | â˛15.31% |
| December 9, 2022 | $0.98 | - |
| September 9, 2022 | $0.98 | - |
| June 10, 2022 | $0.98 | - |
| March 10, 2022 | $0.98 | â˛15.29% |
| December 10, 2021 | $0.85 | - |
| September 10, 2021 | $0.85 | - |
| June 10, 2021 | $0.85 | - |
| March 10, 2021 | $0.85 | â˛14.86% |
| December 10, 2020 | $0.74 | - |
| September 10, 2020 | $0.74 | - |
| June 10, 2020 | $0.74 | - |
| March 10, 2020 | $0.74 | â˛14.73% |
| December 10, 2019 | $0.65 | - |
| September 10, 2019 | $0.65 | - |
| June 10, 2019 | $0.65 | - |
| March 8, 2019 | $0.65 | â˛14.67% |
| December 10, 2018 | $0.56 | - |
| September 10, 2018 | $0.56 | - |
| June 8, 2018 | $0.56 | - |
| March 9, 2018 | $0.56 | â˛8.17% |
| December 8, 2017 | $0.52 | - |
| September 8, 2017 | $0.52 | - |
| June 9, 2017 | $0.52 | - |
| March 10, 2017 | $0.52 | â˛1.96% |
| December 9, 2016 | $0.51 | - |
| September 9, 2016 | $0.51 | - |
| June 10, 2016 | $0.51 | - |
| March 10, 2016 | $0.51 | â˛2.00% |
| December 10, 2015 | $0.50 | - |
| September 10, 2015 | $0.50 | - |
| June 10, 2015 | $0.50 | - |
| March 10, 2015 | $0.50 | â˛2.04% |
| December 10, 2014 | $0.49 | - |
| September 10, 2014 | $0.49 | - |
| June 10, 2014 | $0.49 | - |
| March 10, 2014 | $0.49 | - |
| December 10, 2013 | $0.49 | - |
| September 10, 2013 | $0.49 | - |
| June 10, 2013 | $0.49 | - |
| March 8, 2013 | $0.49 | - |
| December 10, 2012 | $0.49 | - |
| September 10, 2012 | $0.49 | - |
| June 8, 2012 | $0.49 | - |
| March 9, 2012 | $0.49 | - |
| December 9, 2011 | $0.49 | - |
| September 9, 2011 | $0.49 | - |
| June 10, 2011 | $0.49 | - |
| March 10, 2011 | $0.49 | - |
| December 10, 2010 | $0.49 | - |
| September 10, 2010 | $0.49 | - |
| June 10, 2010 | $0.49 | - |
| March 10, 2010 | $0.49 | - |
| December 10, 2009 | $0.49 | - |
| September 10, 2009 | $0.49 | - |
| June 10, 2009 | $0.49 | - |
| March 10, 2009 | $0.49 | â˛4.26% |
| December 10, 2008 | $0.47 | - |
| September 10, 2008 | $0.47 | - |
| June 10, 2008 | $0.47 | - |
| March 10, 2008 | $0.47 | â˛10.59% |
| December 10, 2007 | $0.42 | - |
| September 10, 2007 | $0.42 | - |
| June 8, 2007 | $0.42 | - |
| March 9, 2007 | $0.42 | â˛6.25% |
| December 8, 2006 | $0.40 | - |
| September 8, 2006 | $0.40 | - |
| June 9, 2006 | $0.40 | - |
| March 10, 2006 | $0.40 | â˛5.26% |
| December 9, 2005 | $0.38 | - |
| September 9, 2005 | $0.38 | - |
| June 10, 2005 | $0.38 | - |
| March 10, 2005 | $0.38 | â˛7.04% |
| December 10, 2004 | $0.35 | - |
| September 10, 2004 | $0.35 | - |
| June 10, 2004 | $0.35 | - |
| March 10, 2004 | $0.35 |
Overall Dividend Trend
Dividend per share has changed by+322.54%over the past 21years(comparing first and last payout shown).
About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company with headquarters in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, a Civil War veteran, the company has grown to become one of the largest and most respected names in the pharmaceutical industry. As of 2023, the CEO is David A. Ricks, who has held the position since 2017. Eli Lilly is renowned for its innovation in developing medicines for various therapeutic areas, including diabetes, oncology, neuroscience, and immunology. The company is known for its significant contributions to medical advancements, such as the introduction of insulin as the first commercial treatment for diabetes. In 2022, Eli Lilly reported revenues of approximately $28 billion, reflecting its strong market presence and ongoing commitment to improving global health. With a focus on research and development, Eli Lilly continues to drive forward in creating breakthrough treatments that make life better for people around the world.
AbbVie Inc.(ABBV)
Amgen Inc.(AMGN)
Biogen Inc.(BIIB)
Incyte Corporation(INCY)
Johnson & Johnson(JNJ)
Merck & Co., Inc.(MRK)
Moderna, Inc.(MRNA)
Pfizer Inc.(PFE)
Vertex Pharmaceuticals Incorporated(VRTX)
Viking Therapeutics, Inc.(VKTX)Dividend data last updated:Tue, 20 May 2025 05:57:45 GMT. Financial data is indicative and provided for informational purposes only.